{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:42:33Z","timestamp":1770144153996,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40264-025-01622-w","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:08:02Z","timestamp":1760720882000},"page":"207-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticholinergic Drug Use in Elderly Patients: Compliance with STOPP-START and BEERS Criteria in Spain\u2014A Descriptive Study"],"prefix":"10.1007","volume":"49","author":[{"given":"Javier","family":"Santandreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco F\u00e9lix","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gonz\u00e1lez-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"2","key":"1622_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8.","journal-title":"Lancet Public Health"},{"key":"1622_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1817377","author":"G Araklitis","year":"2020","unstructured":"Araklitis G, Robinson D. The cognitive safety of antimuscarinics in the treatment of overactive bladder. Expert Opin Drug Saf. 2020. https:\/\/doi.org\/10.1080\/14740338.2020.1817377.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"1622_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s41999-021-00481-9.Erratum.In:EurGeriatrMed.2022;13(1):307","volume":"12","author":"MB Zazzara","year":"2021","unstructured":"Zazzara MB, et al. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021;12(3):463\u201373. https:\/\/doi.org\/10.1007\/s41999-021-00481-9.Erratum.In:EurGeriatrMed.2022;13(1):307.","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"1622_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcp.12617","volume":"80","author":"K Ruxton","year":"2015","unstructured":"Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209\u201320.","journal-title":"Br J Clin Pharmacol"},{"key":"1622_CR5","unstructured":"Osakidetza. Departamento de Salud del Gobierno Vasco. Carga anticolin\u00e9rgica: \u00bfc\u00f3mo aligerarla?. Informaci\u00f3n Farmacoterap\u00e9utica (INFAC) 2019;27(5):33\u201339."},{"key":"1622_CR6","unstructured":"PrescQIPP. 2016; B140 Anticholinergic drugs. PrescQIPP. in https:\/\/www.prescqipp.info\/our-resources\/bulletins\/bulletin-140-anticholinergic-drugs\/. Accessed Jan 2025."},{"key":"1622_CR7","unstructured":"Candel Molina M, Esteban Reboll A, Puig Ferrer M. Carga anticolin\u00e9rgica: notas para revisi\u00f3n farmacoterap\u00e9utica de los tratamientos seg\u00fan potencia. Direcci\u00f3n General de Farmacia y Productos Sanitarios. 2020;2:2\u201310."},{"issue":"3","key":"1622_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, et al. Cumulative use of strong anticholinergic medications and incident dementia. JAMA Intern Med. 2015;175(3):401\u20137. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663.","journal-title":"JAMA Intern Med"},{"key":"1622_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1315","volume":"361","author":"K Richardson","year":"2018","unstructured":"Richardson K, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361:k1315. https:\/\/doi.org\/10.1136\/bmj.k1315. (Erratum in: BMJ. 2019;367:l6213. 10.1136\/bmj.l6213).","journal-title":"BMJ"},{"issue":"11","key":"1622_CR10","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","volume":"27","author":"A Kodesh","year":"2019","unstructured":"Kodesh A, et al. Exposure to antidepressant medication and the risk of incident dementia. Am J Geriatr Psychiatry. 2019;27(11):1177\u201388. https:\/\/doi.org\/10.1016\/j.jagp.2019.05.019.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"1622_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O'Mahony","year":"2023","unstructured":"O\u2019Mahony D, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625\u201332. https:\/\/doi.org\/10.1007\/s41999-023-00777-y. (Erratum in: Eur Geriatr Med. 2023 Aug;14(4):633. 10.1007\/s41999-023-00812-y).","journal-title":"Eur Geriatr Med."},{"issue":"7","key":"1622_CR12","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American geriatrics society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201381. https:\/\/doi.org\/10.1111\/jgs.18372.","journal-title":"J Am Geriatr Soc"},{"key":"1622_CR13","unstructured":"Dementia. The NICE-SCIE guideline on supporting people with dementia and their careers in health and social care. London (United Kingdom): National Collaborating Centre for Mental Health. Social Care Institute for Excellence. National Institute for Health and Clinical Excellence (NICE); 2007. National Clinical Practice Guideline Number 42."},{"issue":"1","key":"1622_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rpsm.2013.11.003","volume":"8","author":"J L\u00f3pez-\u00c1lvarez","year":"2015","unstructured":"L\u00f3pez-\u00c1lvarez J, et al. Efecto de los f\u00e1rmacos anticolin\u00e9rgicos en el rendimiento cognitivo de las personas mayores [Effect of anticholinergic drugs on cognitive impairment in the elderly]. Rev Psiquiatr Salud Ment. 2015;8(1):35\u201343. https:\/\/doi.org\/10.1016\/j.rpsm.2013.11.003.","journal-title":"Rev Psiquiatr Salud Ment."},{"issue":"1","key":"1622_CR15","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41598-021-84229-2","volume":"11","author":"T Harnod","year":"2021","unstructured":"Harnod T, et al. Use of bladder antimuscarinics is associated with an increased risk of dementia: a retrospective population-based case-control study. Sci Rep. 2021;11(1):4827. https:\/\/doi.org\/10.1038\/s41598-021-84229-2.","journal-title":"Sci Rep"},{"issue":"1","key":"1622_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/nau.24536","volume":"40","author":"RR Dmochowski","year":"2021","unstructured":"Dmochowski RR, et al. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis. Neurourol Urodyn. 2021;40(1):28\u201337. https:\/\/doi.org\/10.1002\/nau.24536.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"1622_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2125.2011.03961.x","volume":"72","author":"E Callegari","year":"2011","unstructured":"Callegari E, et al. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Br J Clin Pharmacol. 2011;72(2):235\u201346. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.03961.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1622_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084\u201393. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0677.","journal-title":"JAMA Intern Med"},{"key":"1622_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jad.2017.09.016","volume":"226","author":"K Heser","year":"2018","unstructured":"Heser K, et al. Potentially inappropriate medication: association between the use of antidepressant drugs and the subsequent risk for dementia. J Affect Disord. 2018;226:28\u201335. https:\/\/doi.org\/10.1016\/j.jad.2017.09.016.","journal-title":"J Affect Disord"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01622-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01622-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01622-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:28:06Z","timestamp":1769837286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01622-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01622-w","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent was obtained from all co-authors, and no other consent to publish was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable. All data are the property of BIFAP and are not publicly available.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Javier Santandreu contributed to the conception and design of the study, acquisition of data, analysis and interpretation of data, and drafting the article. Francisco F\u00e9lix Caballero contributed to conception and design of the study, acquisition of data, analysis and interpretation of data, and revising the article critically for important intellectual content. Elena Gonz\u00e1lez-Burgos contributed to conception and design of the study, interpretation of data, supervision, drafting the article and revising it critically for important intellectual content. All authors read and approved the final manuscript. The results, discussion, and conclusions of this study are only those of the authors and do not represent in any way the position of the AEMPS on this subject.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"This study was approved by the BIFAP Scientific Committee (24_2022) and by the Regional Research Ethics Committee for Research with medicines in the Community of Madrid (CEIm-R), (number 3_05May2023).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The data and information about this research is owned by BIFAP and is not available.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}}]}}